BioCharge is designed for rotator cuff repair and is a bioresorbable synthetic implant. It’s an onlay scaffold that supports natural healing, promotes cellular activity to encourage native collagen remodeling and reinforces the suture tendon interface.
“Retear rates remain high due to the complexities of tendon disease,” Ronald Bracken, CEO of Atreon, said in the release. “With the introduction of BioCharge, Atreon is the only company offering solutions engineered to support native remodeling at both the tendon-bone and tendon-suture interfaces, resulting in improved treatment options for surgeons and their patients.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
